Hamilton, Brook, Smith & Reynolds, P.C.
Renin inhibitors
The present invention is directed to aspartic protease inhibitors. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.
Vitae Pharmaceuticals, Inc.
C A C C C C C A C C C
C07D A61P C07D C07D C07C C07C C07C A61P C07C C07D C07C
inventional inventional inventional inventional inventional inventional additional inventional additional inventional inventional
John J. Colin M. Suresh B. Patrick T. Lawrence W. Robert D. Wei Salvacion Jing Gerard David A. Zhenrong Linghang Alexey V. Lanqi
Baldwin Tice Singh Flaherty Dillard Simpson Zhao Cacatian Yuan McGeehan Claremon Xu Zhuang Ishchenko Jia